Cargando…
Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study
BACKGROUND: Chemotherapy-induced alopecia (CIA), although generally reversible, is felt as extremely distressing by patients with breast cancer. A certified medical device (Capelli Naturali a Contatto(®)—CNC(®)) was produced to provide patients with a personalized scalp prosthesis, reproducing the p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719124/ https://www.ncbi.nlm.nih.gov/pubmed/36463143 http://dx.doi.org/10.1186/s12905-022-02080-7 |
_version_ | 1784843248463773696 |
---|---|
author | Petruzzi, Alessandra Mancuso, Anna Maria Alfieri, Sara Esposito, Antonella Infante, Gabriele Miceli, Rosalba Ospitali, Stefano Ripamonti, Carla Ida Borreani, Claudia |
author_facet | Petruzzi, Alessandra Mancuso, Anna Maria Alfieri, Sara Esposito, Antonella Infante, Gabriele Miceli, Rosalba Ospitali, Stefano Ripamonti, Carla Ida Borreani, Claudia |
author_sort | Petruzzi, Alessandra |
collection | PubMed |
description | BACKGROUND: Chemotherapy-induced alopecia (CIA), although generally reversible, is felt as extremely distressing by patients with breast cancer. A certified medical device (Capelli Naturali a Contatto(®)—CNC(®)) was produced to provide patients with a personalized scalp prosthesis, reproducing the patient’s original hair, resistant to any type of everyday or sporting activity, and hairdressing. AIMS: The present study aimed to evaluate the impact of the CNC(®) device on the patient’s perception of their body image, psychological wellbeing, satisfaction, strengths and weakness of the CNC(®) device. METHOD: A pilot study was carried out on 21 patients affected by CIA due to recurrent breast cancer. A mixed quantitative/qualitative method was used, including administering a questionnaire and a focus group. RESULTS: Based on the Body Image Scale, body image perception improved after 3 and 6 months using the device in the 20 patients who answered the questionnaire. No significant change over time emerged for the six dimensions investigated by the Italian version of the Psychological Well-Being Scale. The thematic analysis of the focus groups showed six themes: definition of the prosthetic device, acceptance of the proposal, experience with the conventional wig, strengths, weaknesses, economic issues. CONCLUSION: Compared to the previous experience of CIA and the standard wig, the use of the CNC(®) device improved everyday life and may be proposed to women undergoing chemotherapy and expecting alopecia to prevent discomfort, social embarrassment, and compromised body image. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-022-02080-7. |
format | Online Article Text |
id | pubmed-9719124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97191242022-12-04 Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study Petruzzi, Alessandra Mancuso, Anna Maria Alfieri, Sara Esposito, Antonella Infante, Gabriele Miceli, Rosalba Ospitali, Stefano Ripamonti, Carla Ida Borreani, Claudia BMC Womens Health Research Article BACKGROUND: Chemotherapy-induced alopecia (CIA), although generally reversible, is felt as extremely distressing by patients with breast cancer. A certified medical device (Capelli Naturali a Contatto(®)—CNC(®)) was produced to provide patients with a personalized scalp prosthesis, reproducing the patient’s original hair, resistant to any type of everyday or sporting activity, and hairdressing. AIMS: The present study aimed to evaluate the impact of the CNC(®) device on the patient’s perception of their body image, psychological wellbeing, satisfaction, strengths and weakness of the CNC(®) device. METHOD: A pilot study was carried out on 21 patients affected by CIA due to recurrent breast cancer. A mixed quantitative/qualitative method was used, including administering a questionnaire and a focus group. RESULTS: Based on the Body Image Scale, body image perception improved after 3 and 6 months using the device in the 20 patients who answered the questionnaire. No significant change over time emerged for the six dimensions investigated by the Italian version of the Psychological Well-Being Scale. The thematic analysis of the focus groups showed six themes: definition of the prosthetic device, acceptance of the proposal, experience with the conventional wig, strengths, weaknesses, economic issues. CONCLUSION: Compared to the previous experience of CIA and the standard wig, the use of the CNC(®) device improved everyday life and may be proposed to women undergoing chemotherapy and expecting alopecia to prevent discomfort, social embarrassment, and compromised body image. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-022-02080-7. BioMed Central 2022-12-03 /pmc/articles/PMC9719124/ /pubmed/36463143 http://dx.doi.org/10.1186/s12905-022-02080-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Petruzzi, Alessandra Mancuso, Anna Maria Alfieri, Sara Esposito, Antonella Infante, Gabriele Miceli, Rosalba Ospitali, Stefano Ripamonti, Carla Ida Borreani, Claudia Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study |
title | Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study |
title_full | Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study |
title_fullStr | Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study |
title_full_unstemmed | Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study |
title_short | Evaluation of the CNC(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study |
title_sort | evaluation of the cnc(®) prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719124/ https://www.ncbi.nlm.nih.gov/pubmed/36463143 http://dx.doi.org/10.1186/s12905-022-02080-7 |
work_keys_str_mv | AT petruzzialessandra evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy AT mancusoannamaria evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy AT alfierisara evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy AT espositoantonella evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy AT infantegabriele evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy AT micelirosalba evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy AT ospitalistefano evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy AT ripamonticarlaida evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy AT borreaniclaudia evaluationofthecncprostheticsysteminrecurrentbreastcancerpatientswithchemotherapyinducedalopeciaapilotstudy |